BACKGROUND: The relevance of continuity of care in chronic illness is uncertain. OBJECTIVE: We evaluated whether experienced continuity of care for type 2 diabetes is associated with HbA1c, blood pressure or body weight. METHODS: Cohort study in 19 family practices in London, UK. Participants were 209 type 2 diabetic patients with 156 (75%) followed-up at 10 months. Main measures were experienced continuity of care (ECC) by patient questionnaire (mean score 62.1, SD 16.0), satisfaction with care, health-related quality of life [short-form 12 (SF-12)], HbA1c, blood pressure and body weight. Analyses were adjusted for baseline values, age, sex, ethnicity, duration of diabetes, diabetes treatment, education, housing tenure and whether living alone. RESULTS: Experienced continuity scores were obtained for 193 (92%) of participants at baseline and 156 (75%) at follow-up with no difference in outcome measures between those followed-up and those not. Subjects with the highest satisfaction ratings, compared with the lowest, had higher experienced continuity (difference in experienced continuity 7.87, 95% confidence interval 3.22-12.5, P = 0.001). ECC was not associated with HbA1c (adjusted difference per 10-unit increase in ECC score, -0.09%, -0.29 to 0.12%, P = 0.402), systolic blood pressure (-0.41, -2.88 to 2.06 mm Hg, P = 0.746), body mass index (-0.08, -0.34 to 0.18 kg/m(2), P = 0.562) or SF-12 physical component score (0.73, -0.88 to 2.35, P = 0.375). CONCLUSION: Experienced continuity of diabetes care is associated with greater patient satisfaction but not with improved intermediate outcomes during 10 months follow-up in this setting. Studies with more subjects will be required to determine whether continuity of care is associated with the frequency of adverse events.
BACKGROUND: The relevance of continuity of care in chronic illness is uncertain. OBJECTIVE: We evaluated whether experienced continuity of care for type 2 diabetes is associated with HbA1c, blood pressure or body weight. METHODS: Cohort study in 19 family practices in London, UK. Participants were 209 type 2 diabeticpatients with 156 (75%) followed-up at 10 months. Main measures were experienced continuity of care (ECC) by patient questionnaire (mean score 62.1, SD 16.0), satisfaction with care, health-related quality of life [short-form 12 (SF-12)], HbA1c, blood pressure and body weight. Analyses were adjusted for baseline values, age, sex, ethnicity, duration of diabetes, diabetes treatment, education, housing tenure and whether living alone. RESULTS: Experienced continuity scores were obtained for 193 (92%) of participants at baseline and 156 (75%) at follow-up with no difference in outcome measures between those followed-up and those not. Subjects with the highest satisfaction ratings, compared with the lowest, had higher experienced continuity (difference in experienced continuity 7.87, 95% confidence interval 3.22-12.5, P = 0.001). ECC was not associated with HbA1c (adjusted difference per 10-unit increase in ECC score, -0.09%, -0.29 to 0.12%, P = 0.402), systolic blood pressure (-0.41, -2.88 to 2.06 mm Hg, P = 0.746), body mass index (-0.08, -0.34 to 0.18 kg/m(2), P = 0.562) or SF-12 physical component score (0.73, -0.88 to 2.35, P = 0.375). CONCLUSION: Experienced continuity of diabetes care is associated with greater patient satisfaction but not with improved intermediate outcomes during 10 months follow-up in this setting. Studies with more subjects will be required to determine whether continuity of care is associated with the frequency of adverse events.
Authors: Amna Husain; Lisa Barbera; Doris Howell; Rahim Moineddin; Andrea Bezjak; Jonathan Sussman Journal: Support Care Cancer Date: 2012-12-29 Impact factor: 3.603
Authors: Khalida Ismail; Kirsty Winkley; Nicole de Zoysa; Anita Patel; Margaret Heslin; Helen Graves; Stephen Thomas; Dominic Stringer; Daniel Stahl; Stephanie A Amiel Journal: Br J Gen Pract Date: 2018-07-16 Impact factor: 5.386
Authors: Natalie Armstrong; Darrin Baines; Richard Baker; Richard Crossman; Melanie Davies; Ainsley Hardy; Kamlesh Khunti; Sudhesh Kumar; Joseph Paul O'Hare; Neil Raymond; Ponnusamy Saravanan; Nigel Stallard; Ala Szczepura; Andrew Wilson Journal: Trials Date: 2012-09-12 Impact factor: 2.279
Authors: Marta-Beatriz Aller; Josep Maria Colomé; Sina Waibel; Ingrid Vargas; María Luisa Vázquez Journal: Int J Environ Res Public Health Date: 2013-04-09 Impact factor: 3.390